Skip to main content
. Author manuscript; available in PMC: 2009 Aug 17.
Published in final edited form as: J Biol Chem. 1999 Dec 17;274(51):36321–36327. doi: 10.1074/jbc.274.51.36321

TABLE I. Calpain inhibition blocks platelet aggregation.

The initial slope of thrombin-induced platelet aggregation was compared at varying concentrations of inhibitor. The uninhibited rate of aggregation was determined from peptide vehicle (150 mm HEPES-KOH, pH 7.4), in the case of calpastat and calpastat-Ala, or Me2SO vehicle, in the case of calpeptin, MDL, and E64d. NI indicates that no inhibition of aggregation occurred with calpastat-Ala, at the concentrations used for calpastat, and that no inhibition of aggregation occurred with NH4Cl lysosomal inhibition. Rates of thrombin-induced (0.05 units/ml) aggregation of gel-filtered platelets were measured during the first 15 s of aggregation, immediately following shape change. Thrombin-induced shape change was not affected by any of the inhibitors.

Inhibitor IC50
µm
Calpastat 50
Calpastatin 24-mer NI
Calpastat-Ala NI
Calpeptin 150
MDL 240
E64d 340
NH4Cl (10 mm) NI